Allurion Technologies Inc's fundamentals are relatively healthy, and its growth potential is good.Its valuation is considered fairly valued, ranking 193/482 in the Software & IT Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 5.50.In the medium term, the stock price is expected to trend down.Despite strong stock market performance and technicals over the past month, the fundamentals don't support the current trend.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Allurion Technologies Inc's Score
Industry at a Glance
Industry Ranking
193 / 482
Overall Ranking
306 / 4582
Industry
Software & IT Services
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
3
analysts
Buy
Current Rating
5.500
Target Price
+227.38%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Allurion Technologies Inc Highlights
StrengthsRisks
Allurion Technologies, Inc. offers Allurion Program, which is a weight loss platform that combines the Allurion Gastric Balloon for weight loss. The Company offers Allurion Virtual Care Suite, including the Allurion Mobile App for consumers and Allurion Insights for healthcare providers featuring the Iris AI Platform, and the Allurion Connected Scale. The Allurion Balloon is swallowed as a capsule under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia. The Allurion Balloon is a procedure-less intragastric balloon that does not require any surgery, endoscopy, or anesthesia for placement. The balloon is swallowed in a capsule during a discrete outpatient office visit that takes approximately 15 minutes (though times may vary across different outpatient offices). The Allurion Virtual Care Suite is a cutting-edge digital therapeutic that combines AI-powered remote patient monitoring tools with a behavior change program.
Growing
The company is in a growing phase, with the latest annual income totaling USD 32.11M.
Overvalued
The company’s latest PE is -0.01, at a high 3-year percentile range.
Institutional Buying
The latest institutional holdings are 6.53M shares, increasing 33.90% quarter-over-quarter.
Allurion Technologies, Inc. offers Allurion Program, which is a weight loss platform that combines the Allurion Gastric Balloon for weight loss. The Company offers Allurion Virtual Care Suite, including the Allurion Mobile App for consumers and Allurion Insights for healthcare providers featuring the Iris AI Platform, and the Allurion Connected Scale. The Allurion Balloon is swallowed as a capsule under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia. The Allurion Balloon is a procedure-less intragastric balloon that does not require any surgery, endoscopy, or anesthesia for placement. The balloon is swallowed in a capsule during a discrete outpatient office visit that takes approximately 15 minutes (though times may vary across different outpatient offices). The Allurion Virtual Care Suite is a cutting-edge digital therapeutic that combines AI-powered remote patient monitoring tools with a behavior change program.
Ticker SymbolALUR
CompanyAllurion Technologies Inc
CEOGaur (Shantanu)
Websitehttps://www.allurion.com/en
FAQs
What is the current price of Allurion Technologies Inc (ALUR)?
The current price of Allurion Technologies Inc (ALUR) is 1.405.
What is the symbol of Allurion Technologies Inc?
The ticker symbol of Allurion Technologies Inc is ALUR.
What is the 52-week high of Allurion Technologies Inc?
The 52-week high of Allurion Technologies Inc is 16.810.
What is the 52-week low of Allurion Technologies Inc?
The 52-week low of Allurion Technologies Inc is 1.020.
What is the market capitalization of Allurion Technologies Inc?
The market capitalization of Allurion Technologies Inc is 10.91M.
What is the net income of Allurion Technologies Inc?
The net income of Allurion Technologies Inc is -26.15M.
Is Allurion Technologies Inc (ALUR) currently rated as Buy, Hold, or Sell?
According to analysts, Allurion Technologies Inc (ALUR) has an overall rating of Buy, with a price target of 5.500.
What is the Earnings Per Share (EPS TTM) of Allurion Technologies Inc (ALUR)?
The Earnings Per Share (EPS TTM) of Allurion Technologies Inc (ALUR) is -295.460.